MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
24h
Actual
Mínimo
2.65
Máximo
2.75
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +429.2% upside |
Próximas Ganancias | 12 nov 2025 |
---|
El rendimiento pasado no es un indicador fiable de resultados futuros.
1 oct 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Leer
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 14.5 USD 429.2%
Máximo 17 USD
Mínimo 12 USD
De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Mantener
0
Vender
De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$